
COFCODYL LS Junior Syrup by Kivonyx Healthcare Pvt. Ltd. contains Ambroxol Hydrochloride, Levosalbutamol, and Guaiphenesin, a respiratory combination formulated for selected conditions involving productive cough, chest congestion, and bronchospasm. Ambroxol acts as a mucolytic agent that helps thin thick respiratory mucus, while Guaiphenesin supports mucus clearance through its expectorant action. Levosalbutamol is a bronchodilator that helps relax airway muscles when reversible airway narrowing is present. COFCODYL LS Junior may be prescribed for eligible paediatric patients when the combination is approved and clinically appropriate. The oral syrup should be administered strictly according to a paediatrician's prescription, considering the child's age, weight, diagnosis, verified ingredient concentrations, potential adverse effects, and recommended treatment duration.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.